Association between the risk of hypertension and triglyceride glucose index in Chinese regions: a systematic review and dose-response meta-analysis of a regional update

Background Triglyceride-glucose (TyG) index has been reported to be associated with various cardiovascular diseases in recent years. However, the conclusive association between the TyG index and hypertension was not established in the last meta-analysis. Furthermore, it remains unclear whether a linear relationship exists between these two variables. Methods We conducted a comprehensive search of the CNKI, VIP, WanFang Data, CBM, PubMed, EMbase, Web of Science, and The Cochrane Library databases up until May 10, 2023, to identify relevant studies conducted in China. We used Stata version 17.0 and Rstudio version 4.2.1 to analyze the data and assess the association between the TyG index and the risk of hypertension, as well as the dose-response relationship between these two variables. We will select either a random-effects model or a fixed-effects model based on the results of the heterogeneity tests and report 95% confidence intervals accordingly. Results In the end, our analysis encompassed 22 studies involving a total of 668,486 participants, comprising 12 cross-sectional studies and 10 cohort studies. Meta-analysis results showed: Analysis of data from China revealed that an elevated TyG index was associated with a higher risk of developing hypertension, as indicated by an OR/HR of 1.36 [95%CI (1.28–1.45) I2 = 69.0% P < 0.001]. Through meta-regression analysis of multiple covariates, we found that study type, study region, sample size, database source, and study quality score, the above five variables were able to explain 63.0% of the total heterogeneity. The results of the dose-response Meta-analysis showed: The TyG index has a linear relationship with the risk of developing hypertension, as indicated by non-significant coefficients of higher-order terms in the nonlinear model (P > 0.05). The linear trend analysis showed that for every one-unit increase in the TyG index, the risk of developing hypertension increased by 1.5 times [1.532 95%CI (1.294, 1.813) P < 0.001]. However, this result is influenced by the number of studies included in the dose-response analysis and requires further corroboration. Conclusion In the Chinese region, there was an independent association between TyG index and the risk of developing hypertension, with a linear trend. However, the results of the linear trend need to be corrected by the more number of related studies. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023425836.

[1]  Liu Yang,et al.  Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study , 2023, BMC Cardiovascular Disorders.

[2]  Chao-lei Chen,et al.  Association between triglyceride glucose‐body mass index and hypertension in Chinese adults: A cross‐sectional study , 2023, Journal of clinical hypertension.

[3]  Fan Luo,et al.  Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China , 2023, Cardiovascular Diabetology.

[4]  Isao Usui Common metabolic features of hypertension and type 2 diabetes , 2023, Hypertension Research.

[5]  Qi-gui Liu,et al.  Association of triglyceride-glucose index with incident hypertension among non-overweight healthy adults: A cohort study in China. , 2023, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  Yisi Wang,et al.  The Increased Risk of Hypertension Caused by Irrational Dietary Pattern May Be Associated with Th17 Cell in the Middle-Aged and Elderly Rural Residents of Beijing City, Northern China: A 1:1 Matched Case-Control Study , 2023, Nutrients.

[7]  M. Zhang,et al.  Association of triglyceride-glucose index and its 6-year change with risk of hypertension: A prospective cohort study. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  Jing Dong,et al.  Association between surrogate indicators of insulin resistance and risk of type 2 diabetes combined with hypertension among Chinese adults: two independent cohort studies , 2022, Nutrition & Metabolism.

[9]  Elham Shams,et al.  Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes. , 2022, Biochemical pharmacology.

[10]  Wenke Cheng,et al.  Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study , 2022, Diabetology & Metabolic Syndrome.

[11]  S. Li,et al.  Associations of the Triglyceride and Glucose Index With Hypertension Stages, Phenotypes, and Their Progressions Among Middle-Aged and Older Chinese , 2022, International Journal of Public Health.

[12]  F. Lu,et al.  Associations between triglyceride-glucose index and different hypertension subtypes: A population-based study in China , 2022, Frontiers in Cardiovascular Medicine.

[13]  Lei Cao,et al.  Triglyceride-Glucose Index for the Diagnosis of Metabolic Syndrome: A Cross-Sectional Study of 298,652 Individuals Receiving a Health Check-Up in China , 2022, International journal of endocrinology.

[14]  Jian‐Jun Li,et al.  Landscape of cardiometabolic risk factors in Chinese population: a narrative review , 2022, Cardiovascular Diabetology.

[15]  Xin Zhang,et al.  Correlation between non‐insulin‐based insulin resistance indexes and the risk of prehypertension: A cross‐sectional study , 2022, Journal of clinical hypertension.

[16]  P. López-Jaramillo,et al.  Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary , 2021, Hypertension.

[17]  J. Sowers,et al.  Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease , 2021, Hypertension.

[18]  G. Úrrutia,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. , 2021, Revista espanola de cardiologia.

[19]  N. Bello,et al.  Hypertension in Women Across the Lifespan , 2021, Current Atherosclerosis Reports.

[20]  Mihran V. Naljayan,et al.  Hypertension, Obesity, and COVID-19: a Collision of Pandemics , 2021, Current Hypertension Reports.

[21]  W. Yang,et al.  Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.

[22]  M. Ezzati,et al.  Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension , 2021, Nature Reviews Cardiology.

[23]  Meizi Cui,et al.  Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies , 2021, Cardiovascular Diabetology.

[24]  D. Prabhakaran,et al.  Hypertension in Low- and Middle-Income Countries. , 2021, Circulation research.

[25]  J. J. González-Henríquez,et al.  Resting metabolic rate is increased in hypertensive patients with overweight or obesity: Potential mechanisms , 2021, Scandinavian journal of medicine & science in sports.

[26]  N. Cheng,et al.  [Prospective cohort study of relationship of triglyceride, fasting blood-glucose and triglyceride glucose product index with risk of hypertension]. , 2021, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[27]  Zhigang Guo,et al.  The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study , 2021, Journal of clinical hypertension.

[28]  K. Kario,et al.  Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension , 2021, Journal of clinical hypertension.

[29]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[30]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension Global Hypertension Practice Guidelines. , 2020, Hypertension.

[31]  Xuan Li,et al.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. , 2020, The Canadian journal of cardiology.

[32]  Weiqing Wang,et al.  A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study , 2020, Cardiovascular Diabetology.

[33]  Jiang He,et al.  The global epidemiology of hypertension , 2020, Nature Reviews Nephrology.

[34]  Xin Xu,et al.  Metformin use and prostate cancer risk , 2019, Medicine.

[35]  S. Khan,et al.  Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance , 2018, Diabetology & Metabolic Syndrome.

[36]  L. Chuang,et al.  Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study , 2018, Scientific Reports.

[37]  Rongjiong Zheng,et al.  Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study , 2017, Lipids in Health and Disease.

[38]  Song Jian,et al.  Association and interaction between triglyceride–glucose index and obesity on risk of hypertension in middle-aged and elderly adults , 2017, Clinical and experimental hypertension.

[39]  Zhengjing Huang,et al.  Burden of hypertension in China: A nationally representative survey of 174,621 adults. , 2017, International journal of cardiology.

[40]  D. Hipgrave,et al.  Salt and Sodium Intake in China. , 2016, JAMA.

[41]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[42]  M. Wofford,et al.  Hypertension in Postmenopausal Women , 2012, Current Hypertension Reports.

[43]  A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[44]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[45]  Alex J Sutton,et al.  Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. , 2008, Journal of clinical epidemiology.

[46]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[47]  F. Schmidt Meta-Analysis , 2008 .

[48]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[49]  P. Lefèbvre The metabolic syndrome revisited , 2003 .

[50]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[51]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[52]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[53]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[54]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[55]  S. Morton,et al.  A Proposal for Reporting , 2010 .

[56]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[57]  H. Min A 1:1 Matched Case-control Study on the Risk Factors for Inguinal Hernia in Children , 2008 .

[58]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. , 2000, JAMA.

[59]  R. Walker β ℕ Revisited , 1974 .